✦ LIBER ✦

Vasopressin antagonists in heart failure

✍ Scribed by Ladan Golestaneh; Ashok Talreja; Thierry H. Le Jemtel

Book ID: 107539860
Publisher: Current Science Inc.
Year: 2004
Tongue: English
Weight: 244 KB
Volume: 1
Category: Article
ISSN: 1546-9530
DOI: 10.1007/s11897-004-0008-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vasopressin and vasopressin antagonists

Vasopressin and vasopressin antagonists in heart failure and hyponatremia

✍ Dimitrios Farmakis; Gerasimos Filippatos; Dimitrios T. Kremastinos; Mihai Gheorg 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 263 KB

Role of vasopressin antagonists in the m

Role of vasopressin antagonists in the management of acute decompensated heart failure

✍ Cesare Orlandi; Christopher A. Zimmer; Mihai Gheorghiade 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 585 KB

Targeting Hyponatremia and Hemodynamics

Targeting Hyponatremia and Hemodynamics in Acute Decompensated Heart Failure: Is There a Role for Vasopressin Antagonists?

✍ Gregory Valania; Manmeet Singh; Mara T. Slawsky 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 231 KB

Arginine vasopressin (AVP) and treatment

Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)

✍ Natig Gassanov; Nasser Semmo; Mariam Semmo; Amir M. Nia; Uwe Fuhr; Fikret Er 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 359 KB

Coadministration of B-type natriuretic p

Coadministration of B-type natriuretic peptide and the vasopressin-2 receptor antagonist tolvaptan: a novel physiologic strategy to enhance water and sodium excretion without adversely affecting renal or neurohumoral function in experimental congestive heart failure

✍ Lisa C Costello-Boerrigter; Guido Boerrigter; Gail J Harty; John C Burnett 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 404 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.

Endothelin antagonists and heart failure

✍ David Hürlimann; Frank Enseleit; Georg Noll; Thomas F. Lüscher; Frank Ruschitzka 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 733 KB